These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 481366

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
    Matsuo Y, Shimoda S, Sakakida M, Nishida K, Sekigami T, Ichimori S, Ichinose K, Shichiri M, Araki E.
    J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
    [Abstract] [Full Text] [Related]

  • 4. Validation of closed-loop subcutaneous insulin infusion algorithm--application of subcutaneous insulin absorption kinetics.
    Asakawa N, Saito Y, Yamasaki Y, Kawamori R, Shichiri M.
    Diabetes Res; 1987 Aug; 5(4):193-8. PubMed ID: 3311559
    [Abstract] [Full Text] [Related]

  • 5. Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial beta cell.
    Kerner W, Thum C, Tamás G, Beischer W, Clemens AH, Pfeiffer EF.
    Horm Metab Res; 1976 Jul; 8(4):256-61. PubMed ID: 783030
    [Abstract] [Full Text] [Related]

  • 6. The evaluation of glucagon infusion algorithms for a counterregulatory system in artificial endocrine pancreas.
    Yagi T, Yamasaki Y, Bando K, Kawamori R, Kamada T, Shichiri M.
    Med Prog Technol; 1988 Jul; 13(4):195-201. PubMed ID: 2972904
    [Abstract] [Full Text] [Related]

  • 7. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas.
    Sekigami T, Shimoda S, Nishida K, Matsuo Y, Ichimori S, Ichinose K, Shichiri M, Sakakida M, Araki E.
    J Artif Organs; 2004 Jul; 7(2):91-100. PubMed ID: 15309676
    [Abstract] [Full Text] [Related]

  • 8. Continuous glucose monitoring and closed-loop systems.
    Hovorka R.
    Diabet Med; 2006 Jan; 23(1):1-12. PubMed ID: 16409558
    [Abstract] [Full Text] [Related]

  • 9. Development of a closed-loop artificial pancreas.
    Kraegen EW, Whiteside R, Bell D, Chia YO, Lazarus L.
    Horm Metab Res Suppl; 1979 Jan; (8):38-42. PubMed ID: 395087
    [Abstract] [Full Text] [Related]

  • 10. [The dynamic property of glucagon secretion in response to blood glucose--analysis with the aid of the control theory using an artificial endocrine pancreas].
    Yagi T.
    Nihon Naibunpi Gakkai Zasshi; 1985 Feb 20; 61(2):69-79. PubMed ID: 3891432
    [Abstract] [Full Text] [Related]

  • 11. The role of insulin and glucagon in regulating glucose turnover in dogs during exercise.
    Vranic M, Kawamori R, Wrenshall GA.
    Med Sci Sports; 1975 Feb 20; 7(1):27-33. PubMed ID: 1143049
    [Abstract] [Full Text] [Related]

  • 12. The development of wearable-type artificial endocrine pancreas and its usefulness in glycaemic control of human diabetes mellitus.
    Shichiri M, Kawamori R, Hakui N, Asakawa N, Yamasaki Y, Abe H.
    Biomed Biochim Acta; 1984 Feb 20; 43(5):561-8. PubMed ID: 6477542
    [Abstract] [Full Text] [Related]

  • 13. The development of Biostator, a Glucose Controlled Insulin Infusion System (GCIIS).
    Clemens AH, Chang PH, Myers RW.
    Horm Metab Res; 1977 Feb 20; Suppl 7():23-33. PubMed ID: 873440
    [No Abstract] [Full Text] [Related]

  • 14. [Artificial pancreas: study methods and control of glycemia equilibrium in diabetic patients].
    Altomare E, Moulin JP, Vialettes B, Bourelly N, Vague P.
    Boll Soc Ital Biol Sper; 1979 May 30; 55(10):961-6. PubMed ID: 508411
    [Abstract] [Full Text] [Related]

  • 15. Modelling the glucose-insulin system as a basis for the artificial beta cell.
    Fischer U, Salzsieder E, Jutzi E, Albrecht G, Freyse EJ.
    Biomed Biochim Acta; 1984 May 30; 43(5):597-605. PubMed ID: 6383364
    [Abstract] [Full Text] [Related]

  • 16. [Use of an artificial B-cell in clinic and experimental medicine].
    Fischer U, Bruns W, Jutzi E, Ratzmann KP, Abel P, Bombor H, Salzsieder E, Freyse EJ.
    Z Gesamte Inn Med; 1981 Jan 01; 36(1):19-26. PubMed ID: 7013292
    [Abstract] [Full Text] [Related]

  • 17. Studies with an artificial endocrine pancreas.
    Albisser AM, Leibel BS, Zinman B, Murray FT, Zingg W, Botz CK, Denoga A, Marliss EB.
    Arch Intern Med; 1977 May 01; 137(5):639-49. PubMed ID: 856089
    [Abstract] [Full Text] [Related]

  • 18. Determinants of glucose turnover in the pathophysiology of diabetes: an in vivo analysis in diabetic dogs.
    Fisher SJ, Lekas MC, McCall RH, Shi ZQ, Giacca A, Vranic M.
    Diabetes Metab; 1996 Apr 01; 22(2):111-21. PubMed ID: 8792091
    [Abstract] [Full Text] [Related]

  • 19. Blood glucose monitoring and computer regulation by means of an artificial endocrine pancreas.
    Kruse-Jarres JD, Braun G, Naegele R, Bresch M, Lehmann U.
    Horm Metab Res Suppl; 1979 Apr 01; (8):42-5. PubMed ID: 395088
    [Abstract] [Full Text] [Related]

  • 20. Experience with an implantable glucose sensor as a prerequisite of an artificial beta cell.
    Abel P, Müller A, Fischer U.
    Biomed Biochim Acta; 1984 Apr 01; 43(5):577-84. PubMed ID: 6477543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.